Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Michigan

About this trial

This study addresses PTSD symptoms in First Responders and Healthcare workers. Specifically, it tests whether a brief PTSD treatment (talk therapy) effectively treats PTSD when provided to First Responders and Healthcare workers by counselors in Employee Assistance Programs (EAPs).

The central hypothesis is that the PTSD treatment, Prolonged Exposure for Primary Care (PE-PC), will reduce PTSD symptoms and improve functioning, compared to EAP Treatment as Usual (TAU).

Eligibility criteria

Qualifiers

Are employees at an orginization served by a participating EAP

Have a Post-Traumatic Stress Disorder Checklist for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (PCL-5) score ≥33

Have had psychotropic medication stability for at least 4 weeks

Disqualifiers

Severe cognitive impairment that in the judgment of the investigators makes it unlikely that the participant can adhere to the study regimen (as evidenced by confusion, inability to track discussion or answer questions, or other clear and significant indicators of cognitive impairment)

High risk of suicide (defined as meeting criteria for Action Step 3 on the Participant Suicide Risk Screening form: found in protocol)

Need for detoxification

Active psychosis or unmanaged bipolar disorder, as measured by items 12 and 13 of the cross cutting assessment

Trial design

Treatments tested in this trial

  • Prolonged Exposure for Primary Care (PE-PC)
  • EAP Treatment as Usual (TAU)

Treatment groups

410 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Michigan

Lead sponsor

National Institute of Mental Health (NIMH)

Collaborator